Skip to main content
OpenTrials

Clinical trial condition

Liver Cirrhosis

Explore clinical trials studying Liver Cirrhosis. Study availability and eligibility vary by location and protocol.

163 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Liver Cirrhosis trial results

Completed

A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.

NCT06525311

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +10 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • Southern California Research Center, Inc Coronado, California, United States
  • Indiana University School of Medicine - Indianapolis Indianapolis, Indiana, United States
  • Houston Research Institute Houston, Texas, United States
View Trial Details
Completed

A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

NCT05014672

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +10 more
Locations
  • UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • California Liver Research Institute Pasadena, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View all 128 locations
View Trial Details
Completed

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

NCT03112681

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • California Liver Research Institute Pasadena, California, United States
  • Schiff Center for Liver Diseases/University of Miami Miami, Florida, United States
  • Gastrointestional Specialists of Georgia Marietta, Georgia, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
View Trial Details
Completed

RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)

NCT04620733

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The Institute for Liver Health DBA Arizona Liver Health Chandler, Arizona, United States
  • Arkansas Diagnostic Center Little Rock, Arkansas, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • California Liver Research Institute Pasadena, California, United States
View all 134 locations
View Trial Details

Related conditions